SNDX

Conviction 46HealthcareScan · Thu, Jun 25, 2026

SNDX$19.81-0.85%

ResistanceSupportVol 14Insider sell

Vol MA14 2.12M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Syndax Pharmaceuticals IncPHARMACEUTICAL PREPARATIONSwww.syndax.com ↗

Price19.81

Change-0.85%

Gap-0.35%

Rel volume1.97×

Avg volume2.17M

Avg $ vol40.27M

SMA 2018.62

SMA 5020.08

SMA 20019.56

Price vs 50-1.35%

Price vs 200+1.27%

MA stackmixed

50/200 cross—

Supertrendup · 17.67

RSI (14)56

MACD hist0.33

MACD crossbull · 8d

Stoch %K / %D78 / 80

ADX (14)24

+DI / −DI29 / 15

RSI divergence—

MACD divergence—

ATR %+4.32%

ADR %4.24%

52w high25.15

52w low8.73

From 52w high-21.23%

Above 52w low+126.92%

New 52w highNo

SqueezeOff

Bollinger width18.49%

%B0.84

Donchian pos77.59%

Donchian high20.72

Donchian low16.66

AVWAP (52w high)20.68

vs AVWAP high-4.19%

AVWAP (52w low)17.38

vs AVWAP low+13.97%

OBV trendDown

Chaikin MF (20)-0.04

Today vs 20d1.97×

Avg vol (14d)2.12M

Avg vol (20d)2.17M

Avg $ vol (20d)40.27M

Market cap1.76B

RS 3m (vs SPY)-29.08%

RS 6m (vs SPY)-11.54%

RS line new highNo

Trend template4/8

Technical rank44.8

1 week+4.04%

1 month-0.45%

3 months-18.14%

6 months-7.77%

1 year+114.86%

YTD-7.00%

P/E-6.15

P/B42.17

P/S10.18

P/FCF-5.43

EPS-3.29

Div yield—

ROE-685.75%

ROA-60.39%

Debt/Eq8.41

Current5.47

EV/EBITDA—

Gross margin—

Net margin-165.60%

Rev growth627.84%

EPS growth10.46%

Price target37.11

Target upside87.33%

Analyst ratingBuy

Institutional121.58%

Ent. value1.97B

Revenue64.86M

Net income-42.67M

Gross profit—

Free cash flow-323.17M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out88.61M

Employees298

ListedThu, Mar 3, 2016

Free float83.06M

Float %93.5%

Short interest16.64M

Days to cover16.0d

Short volume44.9%

Squeeze score83 / 100

Next earningsMon, Aug 3, 2026 (39d)

EPS forecast−$0.45 · 5 est

Last EPS vs est−$0.48 vs −$0.59

Last surprise+18.6% beat

Setup gradeC

Conviction46 / 100

Pattern quality—

Tech rank44.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance21.62

Support17.83

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SNDX

All disclosures →

No recent disclosed trades by Congress in SNDX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SNDX · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Goldan Keith A. Chief Financial Officer · Common Stock · 2026-06-01	Sell	1.18K	$22K	2026-06-01	2026-06-02
Metzger Michael A Chief Executive Officer · Common Stock · 2026-06-01	Sell	6.85K	$130K	2026-06-01	2026-06-02

SEC filings

EDGAR filings in SNDX · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.